nodes	percent_of_prediction	percent_of_DWPC	metapath
Dorzolamide—CA5B—coronary artery disease	0.327	1	CbGaD
Dorzolamide—CA14—Furosemide—coronary artery disease	0.0373	0.0904	CbGbCtD
Dorzolamide—CA6—Furosemide—coronary artery disease	0.0354	0.0859	CbGbCtD
Dorzolamide—CA5A—Furosemide—coronary artery disease	0.0354	0.0859	CbGbCtD
Dorzolamide—CA7—Furosemide—coronary artery disease	0.0309	0.0749	CbGbCtD
Dorzolamide—CA5B—Furosemide—coronary artery disease	0.0309	0.0749	CbGbCtD
Dorzolamide—CA12—Furosemide—coronary artery disease	0.0265	0.0642	CbGbCtD
Dorzolamide—CA9—Furosemide—coronary artery disease	0.0265	0.0642	CbGbCtD
Dorzolamide—CA1—Furosemide—coronary artery disease	0.0248	0.0601	CbGbCtD
Dorzolamide—CA4—Furosemide—coronary artery disease	0.0233	0.0565	CbGbCtD
Dorzolamide—CA2—Furosemide—coronary artery disease	0.0214	0.0519	CbGbCtD
Dorzolamide—CA5B—cervicothoracic ganglion—coronary artery disease	0.0137	0.364	CbGeAlD
Dorzolamide—CYP2C9—Fenofibrate—coronary artery disease	0.011	0.0266	CbGbCtD
Dorzolamide—CA5B—sinoatrial node—coronary artery disease	0.00884	0.235	CbGeAlD
Dorzolamide—CYP2C9—Gemfibrozil—coronary artery disease	0.00876	0.0212	CbGbCtD
Dorzolamide—CYP2C9—Clopidogrel—coronary artery disease	0.00759	0.0184	CbGbCtD
Dorzolamide—CYP3A4—Ticagrelor—coronary artery disease	0.00715	0.0173	CbGbCtD
Dorzolamide—CYP2C9—Pitavastatin—coronary artery disease	0.00664	0.0161	CbGbCtD
Dorzolamide—CYP2C9—Valsartan—coronary artery disease	0.00646	0.0156	CbGbCtD
Dorzolamide—CYP3A4—Fenofibrate—coronary artery disease	0.00637	0.0154	CbGbCtD
Dorzolamide—CYP3A4—Gemfibrozil—coronary artery disease	0.00509	0.0123	CbGbCtD
Dorzolamide—CYP2C9—Rosuvastatin—coronary artery disease	0.00489	0.0119	CbGbCtD
Dorzolamide—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00477	0.0116	CbGbCtD
Dorzolamide—CYP2C9—Simvastatin—coronary artery disease	0.00455	0.011	CbGbCtD
Dorzolamide—CYP2C9—cardial valve—coronary artery disease	0.00451	0.12	CbGeAlD
Dorzolamide—CYP2C9—Pravastatin—coronary artery disease	0.00445	0.0108	CbGbCtD
Dorzolamide—CYP2C9—Lovastatin—coronary artery disease	0.00445	0.0108	CbGbCtD
Dorzolamide—CYP3A4—Clopidogrel—coronary artery disease	0.00442	0.0107	CbGbCtD
Dorzolamide—CYP3A4—Eplerenone—coronary artery disease	0.00411	0.00995	CbGbCtD
Dorzolamide—CYP2C9—Atorvastatin—coronary artery disease	0.00405	0.00983	CbGbCtD
Dorzolamide—CYP2C9—Losartan—coronary artery disease	0.00371	0.00899	CbGbCtD
Dorzolamide—CYP3A4—Enalapril—coronary artery disease	0.00366	0.00887	CbGbCtD
Dorzolamide—Brinzolamide—CA5B—coronary artery disease	0.00296	1	CrCbGaD
Dorzolamide—CYP3A4—Rosuvastatin—coronary artery disease	0.00285	0.0069	CbGbCtD
Dorzolamide—CYP3A4—Ezetimibe—coronary artery disease	0.00285	0.0069	CbGbCtD
Dorzolamide—CYP3A4—Simvastatin—coronary artery disease	0.00265	0.00641	CbGbCtD
Dorzolamide—CYP3A4—Lovastatin—coronary artery disease	0.00259	0.00627	CbGbCtD
Dorzolamide—CYP3A4—Pravastatin—coronary artery disease	0.00259	0.00627	CbGbCtD
Dorzolamide—CYP3A4—Atorvastatin—coronary artery disease	0.00236	0.00571	CbGbCtD
Dorzolamide—CYP3A4—Losartan—coronary artery disease	0.00216	0.00523	CbGbCtD
Dorzolamide—CA14—cardiac ventricle—coronary artery disease	0.00112	0.0298	CbGeAlD
Dorzolamide—CA14—heart—coronary artery disease	0.000736	0.0196	CbGeAlD
Dorzolamide—CA14—cardiac atrium—coronary artery disease	0.00063	0.0167	CbGeAlD
Dorzolamide—CA4—cardiac ventricle—coronary artery disease	0.000542	0.0144	CbGeAlD
Dorzolamide—CA5B—heart—coronary artery disease	0.000515	0.0137	CbGeAlD
Dorzolamide—CA4—myocardium—coronary artery disease	0.000509	0.0135	CbGeAlD
Dorzolamide—CA5B—cardiovascular system—coronary artery disease	0.000486	0.0129	CbGeAlD
Dorzolamide—CA1—heart—coronary artery disease	0.000455	0.0121	CbGeAlD
Dorzolamide—CA2—cardiac ventricle—coronary artery disease	0.000449	0.0119	CbGeAlD
Dorzolamide—CA5B—cardiac atrium—coronary artery disease	0.000441	0.0117	CbGeAlD
Dorzolamide—CA1—cardiovascular system—coronary artery disease	0.000429	0.0114	CbGeAlD
Dorzolamide—CA2—myocardium—coronary artery disease	0.000422	0.0112	CbGeAlD
Dorzolamide—CA5B—blood—coronary artery disease	0.000384	0.0102	CbGeAlD
Dorzolamide—CA4—heart—coronary artery disease	0.000356	0.00945	CbGeAlD
Dorzolamide—CA1—blood—coronary artery disease	0.000339	0.00902	CbGeAlD
Dorzolamide—CA4—cardiovascular system—coronary artery disease	0.000335	0.00891	CbGeAlD
Dorzolamide—CA4—cardiac atrium—coronary artery disease	0.000304	0.00808	CbGeAlD
Dorzolamide—CA2—heart—coronary artery disease	0.000295	0.00783	CbGeAlD
Dorzolamide—CA2—cardiovascular system—coronary artery disease	0.000278	0.00739	CbGeAlD
Dorzolamide—CA4—blood—coronary artery disease	0.000265	0.00705	CbGeAlD
Dorzolamide—CA2—cardiac atrium—coronary artery disease	0.000252	0.0067	CbGeAlD
Dorzolamide—CYP2C9—heart—coronary artery disease	0.000249	0.00663	CbGeAlD
Dorzolamide—CYP2C9—cardiovascular system—coronary artery disease	0.000235	0.00625	CbGeAlD
Dorzolamide—CA2—blood—coronary artery disease	0.00022	0.00584	CbGeAlD
Dorzolamide—CYP2C9—blood—coronary artery disease	0.000186	0.00495	CbGeAlD
Dorzolamide—CYP3A4—blood—coronary artery disease	0.000142	0.00377	CbGeAlD
Dorzolamide—Pruritus—Valsartan—coronary artery disease	3.82e-05	0.000254	CcSEcCtD
Dorzolamide—Dry mouth—Ramipril—coronary artery disease	3.82e-05	0.000254	CcSEcCtD
Dorzolamide—Arthralgia—Timolol—coronary artery disease	3.82e-05	0.000253	CcSEcCtD
Dorzolamide—Chest pain—Timolol—coronary artery disease	3.82e-05	0.000253	CcSEcCtD
Dorzolamide—Vomiting—Ezetimibe—coronary artery disease	3.81e-05	0.000253	CcSEcCtD
Dorzolamide—Hypersensitivity—Pravastatin—coronary artery disease	3.81e-05	0.000253	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Perindopril—coronary artery disease	3.8e-05	0.000253	CcSEcCtD
Dorzolamide—Anxiety—Timolol—coronary artery disease	3.8e-05	0.000253	CcSEcCtD
Dorzolamide—Angioedema—Lisinopril—coronary artery disease	3.8e-05	0.000252	CcSEcCtD
Dorzolamide—Pruritus—Olmesartan—coronary artery disease	3.8e-05	0.000252	CcSEcCtD
Dorzolamide—Decreased appetite—Losartan—coronary artery disease	3.79e-05	0.000252	CcSEcCtD
Dorzolamide—Body temperature increased—Captopril—coronary artery disease	3.79e-05	0.000252	CcSEcCtD
Dorzolamide—Abdominal pain—Captopril—coronary artery disease	3.79e-05	0.000252	CcSEcCtD
Dorzolamide—Dizziness—Simvastatin—coronary artery disease	3.78e-05	0.000251	CcSEcCtD
Dorzolamide—Rash—Ezetimibe—coronary artery disease	3.78e-05	0.000251	CcSEcCtD
Dorzolamide—Dermatitis—Ezetimibe—coronary artery disease	3.77e-05	0.000251	CcSEcCtD
Dorzolamide—Confusional state—Ramipril—coronary artery disease	3.77e-05	0.000251	CcSEcCtD
Dorzolamide—Discomfort—Timolol—coronary artery disease	3.77e-05	0.00025	CcSEcCtD
Dorzolamide—Asthenia—Niacin—coronary artery disease	3.76e-05	0.00025	CcSEcCtD
Dorzolamide—Fatigue—Losartan—coronary artery disease	3.76e-05	0.00025	CcSEcCtD
Dorzolamide—Headache—Ezetimibe—coronary artery disease	3.75e-05	0.000249	CcSEcCtD
Dorzolamide—Anaphylactic shock—Ramipril—coronary artery disease	3.74e-05	0.000248	CcSEcCtD
Dorzolamide—Oedema—Ramipril—coronary artery disease	3.74e-05	0.000248	CcSEcCtD
Dorzolamide—Vertigo—Lisinopril—coronary artery disease	3.74e-05	0.000248	CcSEcCtD
Dorzolamide—Dry mouth—Timolol—coronary artery disease	3.73e-05	0.000248	CcSEcCtD
Dorzolamide—Pain—Losartan—coronary artery disease	3.73e-05	0.000248	CcSEcCtD
Dorzolamide—Syncope—Lisinopril—coronary artery disease	3.73e-05	0.000248	CcSEcCtD
Dorzolamide—Vomiting—Eplerenone—coronary artery disease	3.73e-05	0.000248	CcSEcCtD
Dorzolamide—Feeling abnormal—Furosemide—coronary artery disease	3.73e-05	0.000248	CcSEcCtD
Dorzolamide—Nausea—Fenofibrate—coronary artery disease	3.72e-05	0.000247	CcSEcCtD
Dorzolamide—Pruritus—Niacin—coronary artery disease	3.71e-05	0.000246	CcSEcCtD
Dorzolamide—Asthenia—Pravastatin—coronary artery disease	3.71e-05	0.000246	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Furosemide—coronary artery disease	3.7e-05	0.000246	CcSEcCtD
Dorzolamide—Rash—Eplerenone—coronary artery disease	3.7e-05	0.000246	CcSEcCtD
Dorzolamide—Urticaria—Perindopril—coronary artery disease	3.7e-05	0.000245	CcSEcCtD
Dorzolamide—Hypersensitivity—Trandolapril—coronary artery disease	3.7e-05	0.000245	CcSEcCtD
Dorzolamide—Dermatitis—Eplerenone—coronary artery disease	3.69e-05	0.000245	CcSEcCtD
Dorzolamide—Diarrhoea—Valsartan—coronary artery disease	3.69e-05	0.000245	CcSEcCtD
Dorzolamide—Confusional state—Timolol—coronary artery disease	3.69e-05	0.000245	CcSEcCtD
Dorzolamide—Shock—Ramipril—coronary artery disease	3.68e-05	0.000244	CcSEcCtD
Dorzolamide—Hypersensitivity—Enalapril—coronary artery disease	3.68e-05	0.000244	CcSEcCtD
Dorzolamide—Body temperature increased—Perindopril—coronary artery disease	3.68e-05	0.000244	CcSEcCtD
Dorzolamide—Abdominal pain—Perindopril—coronary artery disease	3.68e-05	0.000244	CcSEcCtD
Dorzolamide—Palpitations—Lisinopril—coronary artery disease	3.67e-05	0.000244	CcSEcCtD
Dorzolamide—Diarrhoea—Olmesartan—coronary artery disease	3.67e-05	0.000244	CcSEcCtD
Dorzolamide—Headache—Eplerenone—coronary artery disease	3.67e-05	0.000244	CcSEcCtD
Dorzolamide—Anaphylactic shock—Timolol—coronary artery disease	3.66e-05	0.000243	CcSEcCtD
Dorzolamide—Oedema—Timolol—coronary artery disease	3.66e-05	0.000243	CcSEcCtD
Dorzolamide—Pruritus—Pravastatin—coronary artery disease	3.66e-05	0.000243	CcSEcCtD
Dorzolamide—Loss of consciousness—Lisinopril—coronary artery disease	3.66e-05	0.000243	CcSEcCtD
Dorzolamide—Nausea—Clopidogrel—coronary artery disease	3.65e-05	0.000243	CcSEcCtD
Dorzolamide—Vomiting—Simvastatin—coronary artery disease	3.63e-05	0.000241	CcSEcCtD
Dorzolamide—Hypersensitivity—Telmisartan—coronary artery disease	3.63e-05	0.000241	CcSEcCtD
Dorzolamide—Cough—Lisinopril—coronary artery disease	3.63e-05	0.000241	CcSEcCtD
Dorzolamide—Nausea—Lovastatin—coronary artery disease	3.63e-05	0.000241	CcSEcCtD
Dorzolamide—Hyperhidrosis—Ramipril—coronary artery disease	3.62e-05	0.00024	CcSEcCtD
Dorzolamide—Rash—Simvastatin—coronary artery disease	3.6e-05	0.000239	CcSEcCtD
Dorzolamide—Dermatitis—Simvastatin—coronary artery disease	3.6e-05	0.000239	CcSEcCtD
Dorzolamide—Asthenia—Trandolapril—coronary artery disease	3.6e-05	0.000239	CcSEcCtD
Dorzolamide—Shock—Timolol—coronary artery disease	3.6e-05	0.000239	CcSEcCtD
Dorzolamide—Feeling abnormal—Losartan—coronary artery disease	3.6e-05	0.000239	CcSEcCtD
Dorzolamide—Urticaria—Furosemide—coronary artery disease	3.59e-05	0.000239	CcSEcCtD
Dorzolamide—Diarrhoea—Niacin—coronary artery disease	3.59e-05	0.000238	CcSEcCtD
Dorzolamide—Asthenia—Enalapril—coronary artery disease	3.59e-05	0.000238	CcSEcCtD
Dorzolamide—Headache—Simvastatin—coronary artery disease	3.58e-05	0.000238	CcSEcCtD
Dorzolamide—Abdominal pain—Furosemide—coronary artery disease	3.58e-05	0.000237	CcSEcCtD
Dorzolamide—Body temperature increased—Furosemide—coronary artery disease	3.58e-05	0.000237	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Losartan—coronary artery disease	3.57e-05	0.000237	CcSEcCtD
Dorzolamide—Dizziness—Valsartan—coronary artery disease	3.57e-05	0.000237	CcSEcCtD
Dorzolamide—Anorexia—Ramipril—coronary artery disease	3.57e-05	0.000237	CcSEcCtD
Dorzolamide—Nausea—Ezetimibe—coronary artery disease	3.56e-05	0.000236	CcSEcCtD
Dorzolamide—Dizziness—Olmesartan—coronary artery disease	3.55e-05	0.000236	CcSEcCtD
Dorzolamide—Pruritus—Trandolapril—coronary artery disease	3.55e-05	0.000236	CcSEcCtD
Dorzolamide—Chest pain—Lisinopril—coronary artery disease	3.54e-05	0.000235	CcSEcCtD
Dorzolamide—Arthralgia—Lisinopril—coronary artery disease	3.54e-05	0.000235	CcSEcCtD
Dorzolamide—Hyperhidrosis—Timolol—coronary artery disease	3.54e-05	0.000235	CcSEcCtD
Dorzolamide—Asthenia—Telmisartan—coronary artery disease	3.54e-05	0.000235	CcSEcCtD
Dorzolamide—Pruritus—Enalapril—coronary artery disease	3.54e-05	0.000235	CcSEcCtD
Dorzolamide—Diarrhoea—Pravastatin—coronary artery disease	3.53e-05	0.000235	CcSEcCtD
Dorzolamide—Anxiety—Lisinopril—coronary artery disease	3.53e-05	0.000234	CcSEcCtD
Dorzolamide—Discomfort—Lisinopril—coronary artery disease	3.5e-05	0.000232	CcSEcCtD
Dorzolamide—Hypotension—Ramipril—coronary artery disease	3.5e-05	0.000232	CcSEcCtD
Dorzolamide—Anorexia—Timolol—coronary artery disease	3.49e-05	0.000232	CcSEcCtD
Dorzolamide—Pruritus—Telmisartan—coronary artery disease	3.49e-05	0.000232	CcSEcCtD
Dorzolamide—Nausea—Eplerenone—coronary artery disease	3.48e-05	0.000231	CcSEcCtD
Dorzolamide—Dizziness—Niacin—coronary artery disease	3.47e-05	0.00023	CcSEcCtD
Dorzolamide—Urticaria—Losartan—coronary artery disease	3.47e-05	0.00023	CcSEcCtD
Dorzolamide—Dry mouth—Lisinopril—coronary artery disease	3.46e-05	0.00023	CcSEcCtD
Dorzolamide—Abdominal pain—Losartan—coronary artery disease	3.45e-05	0.000229	CcSEcCtD
Dorzolamide—Body temperature increased—Losartan—coronary artery disease	3.45e-05	0.000229	CcSEcCtD
Dorzolamide—Asthenia—Captopril—coronary artery disease	3.44e-05	0.000228	CcSEcCtD
Dorzolamide—Diarrhoea—Trandolapril—coronary artery disease	3.43e-05	0.000228	CcSEcCtD
Dorzolamide—Vomiting—Valsartan—coronary artery disease	3.43e-05	0.000228	CcSEcCtD
Dorzolamide—Confusional state—Lisinopril—coronary artery disease	3.42e-05	0.000227	CcSEcCtD
Dorzolamide—Diarrhoea—Enalapril—coronary artery disease	3.42e-05	0.000227	CcSEcCtD
Dorzolamide—Hypotension—Timolol—coronary artery disease	3.42e-05	0.000227	CcSEcCtD
Dorzolamide—Dizziness—Pravastatin—coronary artery disease	3.42e-05	0.000227	CcSEcCtD
Dorzolamide—Vomiting—Olmesartan—coronary artery disease	3.41e-05	0.000227	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Ramipril—coronary artery disease	3.41e-05	0.000226	CcSEcCtD
Dorzolamide—Rash—Valsartan—coronary artery disease	3.4e-05	0.000226	CcSEcCtD
Dorzolamide—Dermatitis—Valsartan—coronary artery disease	3.4e-05	0.000226	CcSEcCtD
Dorzolamide—Nausea—Simvastatin—coronary artery disease	3.39e-05	0.000225	CcSEcCtD
Dorzolamide—Anaphylactic shock—Lisinopril—coronary artery disease	3.39e-05	0.000225	CcSEcCtD
Dorzolamide—Oedema—Lisinopril—coronary artery disease	3.39e-05	0.000225	CcSEcCtD
Dorzolamide—Pruritus—Captopril—coronary artery disease	3.39e-05	0.000225	CcSEcCtD
Dorzolamide—Rash—Olmesartan—coronary artery disease	3.39e-05	0.000225	CcSEcCtD
Dorzolamide—Insomnia—Ramipril—coronary artery disease	3.38e-05	0.000225	CcSEcCtD
Dorzolamide—Dermatitis—Olmesartan—coronary artery disease	3.38e-05	0.000225	CcSEcCtD
Dorzolamide—Headache—Valsartan—coronary artery disease	3.38e-05	0.000224	CcSEcCtD
Dorzolamide—Diarrhoea—Telmisartan—coronary artery disease	3.37e-05	0.000224	CcSEcCtD
Dorzolamide—Headache—Olmesartan—coronary artery disease	3.36e-05	0.000223	CcSEcCtD
Dorzolamide—Paraesthesia—Ramipril—coronary artery disease	3.36e-05	0.000223	CcSEcCtD
Dorzolamide—Shock—Lisinopril—coronary artery disease	3.34e-05	0.000222	CcSEcCtD
Dorzolamide—Asthenia—Perindopril—coronary artery disease	3.34e-05	0.000222	CcSEcCtD
Dorzolamide—Dyspnoea—Ramipril—coronary artery disease	3.34e-05	0.000222	CcSEcCtD
Dorzolamide—Vomiting—Niacin—coronary artery disease	3.34e-05	0.000222	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Timolol—coronary artery disease	3.33e-05	0.000221	CcSEcCtD
Dorzolamide—Hypersensitivity—Furosemide—coronary artery disease	3.33e-05	0.000221	CcSEcCtD
Dorzolamide—Somnolence—Ramipril—coronary artery disease	3.33e-05	0.000221	CcSEcCtD
Dorzolamide—Dizziness—Trandolapril—coronary artery disease	3.32e-05	0.00022	CcSEcCtD
Dorzolamide—Insomnia—Timolol—coronary artery disease	3.31e-05	0.00022	CcSEcCtD
Dorzolamide—Rash—Niacin—coronary artery disease	3.31e-05	0.00022	CcSEcCtD
Dorzolamide—Dermatitis—Niacin—coronary artery disease	3.31e-05	0.000219	CcSEcCtD
Dorzolamide—Dizziness—Enalapril—coronary artery disease	3.3e-05	0.000219	CcSEcCtD
Dorzolamide—Dyspepsia—Ramipril—coronary artery disease	3.29e-05	0.000219	CcSEcCtD
Dorzolamide—Pruritus—Perindopril—coronary artery disease	3.29e-05	0.000219	CcSEcCtD
Dorzolamide—Headache—Niacin—coronary artery disease	3.29e-05	0.000218	CcSEcCtD
Dorzolamide—Paraesthesia—Timolol—coronary artery disease	3.29e-05	0.000218	CcSEcCtD
Dorzolamide—Vomiting—Pravastatin—coronary artery disease	3.28e-05	0.000218	CcSEcCtD
Dorzolamide—Hyperhidrosis—Lisinopril—coronary artery disease	3.28e-05	0.000218	CcSEcCtD
Dorzolamide—Diarrhoea—Captopril—coronary artery disease	3.28e-05	0.000218	CcSEcCtD
Dorzolamide—Dyspnoea—Timolol—coronary artery disease	3.26e-05	0.000217	CcSEcCtD
Dorzolamide—Dizziness—Telmisartan—coronary artery disease	3.26e-05	0.000216	CcSEcCtD
Dorzolamide—Rash—Pravastatin—coronary artery disease	3.26e-05	0.000216	CcSEcCtD
Dorzolamide—Dermatitis—Pravastatin—coronary artery disease	3.25e-05	0.000216	CcSEcCtD
Dorzolamide—Decreased appetite—Ramipril—coronary artery disease	3.25e-05	0.000216	CcSEcCtD
Dorzolamide—Somnolence—Timolol—coronary artery disease	3.25e-05	0.000216	CcSEcCtD
Dorzolamide—Asthenia—Furosemide—coronary artery disease	3.25e-05	0.000216	CcSEcCtD
Dorzolamide—Headache—Pravastatin—coronary artery disease	3.24e-05	0.000215	CcSEcCtD
Dorzolamide—Anorexia—Lisinopril—coronary artery disease	3.24e-05	0.000215	CcSEcCtD
Dorzolamide—Fatigue—Ramipril—coronary artery disease	3.23e-05	0.000214	CcSEcCtD
Dorzolamide—Dyspepsia—Timolol—coronary artery disease	3.22e-05	0.000214	CcSEcCtD
Dorzolamide—Hypersensitivity—Losartan—coronary artery disease	3.22e-05	0.000214	CcSEcCtD
Dorzolamide—Nausea—Valsartan—coronary artery disease	3.21e-05	0.000213	CcSEcCtD
Dorzolamide—Pruritus—Furosemide—coronary artery disease	3.2e-05	0.000213	CcSEcCtD
Dorzolamide—Nausea—Olmesartan—coronary artery disease	3.19e-05	0.000212	CcSEcCtD
Dorzolamide—Vomiting—Trandolapril—coronary artery disease	3.19e-05	0.000212	CcSEcCtD
Dorzolamide—Diarrhoea—Perindopril—coronary artery disease	3.18e-05	0.000211	CcSEcCtD
Dorzolamide—Decreased appetite—Timolol—coronary artery disease	3.18e-05	0.000211	CcSEcCtD
Dorzolamide—Vomiting—Enalapril—coronary artery disease	3.18e-05	0.000211	CcSEcCtD
Dorzolamide—Hypotension—Lisinopril—coronary artery disease	3.17e-05	0.000211	CcSEcCtD
Dorzolamide—Dizziness—Captopril—coronary artery disease	3.17e-05	0.00021	CcSEcCtD
Dorzolamide—Rash—Trandolapril—coronary artery disease	3.16e-05	0.00021	CcSEcCtD
Dorzolamide—Dermatitis—Trandolapril—coronary artery disease	3.16e-05	0.00021	CcSEcCtD
Dorzolamide—Fatigue—Timolol—coronary artery disease	3.15e-05	0.000209	CcSEcCtD
Dorzolamide—Rash—Enalapril—coronary artery disease	3.15e-05	0.000209	CcSEcCtD
Dorzolamide—Dermatitis—Enalapril—coronary artery disease	3.15e-05	0.000209	CcSEcCtD
Dorzolamide—Headache—Trandolapril—coronary artery disease	3.14e-05	0.000209	CcSEcCtD
Dorzolamide—Vomiting—Telmisartan—coronary artery disease	3.13e-05	0.000208	CcSEcCtD
Dorzolamide—Asthenia—Losartan—coronary artery disease	3.13e-05	0.000208	CcSEcCtD
Dorzolamide—Headache—Enalapril—coronary artery disease	3.13e-05	0.000208	CcSEcCtD
Dorzolamide—Pain—Timolol—coronary artery disease	3.13e-05	0.000208	CcSEcCtD
Dorzolamide—Nausea—Niacin—coronary artery disease	3.12e-05	0.000207	CcSEcCtD
Dorzolamide—Rash—Telmisartan—coronary artery disease	3.11e-05	0.000206	CcSEcCtD
Dorzolamide—Dermatitis—Telmisartan—coronary artery disease	3.1e-05	0.000206	CcSEcCtD
Dorzolamide—Diarrhoea—Furosemide—coronary artery disease	3.09e-05	0.000206	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Lisinopril—coronary artery disease	3.09e-05	0.000205	CcSEcCtD
Dorzolamide—Pruritus—Losartan—coronary artery disease	3.09e-05	0.000205	CcSEcCtD
Dorzolamide—Headache—Telmisartan—coronary artery disease	3.09e-05	0.000205	CcSEcCtD
Dorzolamide—Feeling abnormal—Ramipril—coronary artery disease	3.08e-05	0.000205	CcSEcCtD
Dorzolamide—Dizziness—Perindopril—coronary artery disease	3.08e-05	0.000204	CcSEcCtD
Dorzolamide—Insomnia—Lisinopril—coronary artery disease	3.07e-05	0.000204	CcSEcCtD
Dorzolamide—Nausea—Pravastatin—coronary artery disease	3.07e-05	0.000204	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Ramipril—coronary artery disease	3.06e-05	0.000203	CcSEcCtD
Dorzolamide—Paraesthesia—Lisinopril—coronary artery disease	3.05e-05	0.000202	CcSEcCtD
Dorzolamide—Vomiting—Captopril—coronary artery disease	3.05e-05	0.000202	CcSEcCtD
Dorzolamide—Dyspnoea—Lisinopril—coronary artery disease	3.03e-05	0.000201	CcSEcCtD
Dorzolamide—Rash—Captopril—coronary artery disease	3.02e-05	0.000201	CcSEcCtD
Dorzolamide—Dermatitis—Captopril—coronary artery disease	3.02e-05	0.0002	CcSEcCtD
Dorzolamide—Somnolence—Lisinopril—coronary artery disease	3.02e-05	0.0002	CcSEcCtD
Dorzolamide—Feeling abnormal—Timolol—coronary artery disease	3.01e-05	0.0002	CcSEcCtD
Dorzolamide—Headache—Captopril—coronary artery disease	3e-05	0.000199	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Timolol—coronary artery disease	2.99e-05	0.000199	CcSEcCtD
Dorzolamide—Dizziness—Furosemide—coronary artery disease	2.99e-05	0.000199	CcSEcCtD
Dorzolamide—Dyspepsia—Lisinopril—coronary artery disease	2.99e-05	0.000198	CcSEcCtD
Dorzolamide—Diarrhoea—Losartan—coronary artery disease	2.99e-05	0.000198	CcSEcCtD
Dorzolamide—Nausea—Trandolapril—coronary artery disease	2.98e-05	0.000198	CcSEcCtD
Dorzolamide—Urticaria—Ramipril—coronary artery disease	2.97e-05	0.000197	CcSEcCtD
Dorzolamide—Nausea—Enalapril—coronary artery disease	2.97e-05	0.000197	CcSEcCtD
Dorzolamide—Vomiting—Perindopril—coronary artery disease	2.96e-05	0.000196	CcSEcCtD
Dorzolamide—Abdominal pain—Ramipril—coronary artery disease	2.96e-05	0.000196	CcSEcCtD
Dorzolamide—Body temperature increased—Ramipril—coronary artery disease	2.96e-05	0.000196	CcSEcCtD
Dorzolamide—Decreased appetite—Lisinopril—coronary artery disease	2.95e-05	0.000196	CcSEcCtD
Dorzolamide—Rash—Perindopril—coronary artery disease	2.93e-05	0.000195	CcSEcCtD
Dorzolamide—Dermatitis—Perindopril—coronary artery disease	2.93e-05	0.000195	CcSEcCtD
Dorzolamide—Nausea—Telmisartan—coronary artery disease	2.93e-05	0.000194	CcSEcCtD
Dorzolamide—Fatigue—Lisinopril—coronary artery disease	2.93e-05	0.000194	CcSEcCtD
Dorzolamide—Headache—Perindopril—coronary artery disease	2.91e-05	0.000194	CcSEcCtD
Dorzolamide—Urticaria—Timolol—coronary artery disease	2.91e-05	0.000193	CcSEcCtD
Dorzolamide—Pain—Lisinopril—coronary artery disease	2.9e-05	0.000193	CcSEcCtD
Dorzolamide—Body temperature increased—Timolol—coronary artery disease	2.89e-05	0.000192	CcSEcCtD
Dorzolamide—Abdominal pain—Timolol—coronary artery disease	2.89e-05	0.000192	CcSEcCtD
Dorzolamide—Dizziness—Losartan—coronary artery disease	2.89e-05	0.000192	CcSEcCtD
Dorzolamide—Vomiting—Furosemide—coronary artery disease	2.88e-05	0.000191	CcSEcCtD
Dorzolamide—Rash—Furosemide—coronary artery disease	2.85e-05	0.000189	CcSEcCtD
Dorzolamide—Dermatitis—Furosemide—coronary artery disease	2.85e-05	0.000189	CcSEcCtD
Dorzolamide—Nausea—Captopril—coronary artery disease	2.85e-05	0.000189	CcSEcCtD
Dorzolamide—Headache—Furosemide—coronary artery disease	2.83e-05	0.000188	CcSEcCtD
Dorzolamide—Feeling abnormal—Lisinopril—coronary artery disease	2.8e-05	0.000186	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Lisinopril—coronary artery disease	2.78e-05	0.000184	CcSEcCtD
Dorzolamide—Vomiting—Losartan—coronary artery disease	2.77e-05	0.000184	CcSEcCtD
Dorzolamide—Nausea—Perindopril—coronary artery disease	2.76e-05	0.000184	CcSEcCtD
Dorzolamide—Hypersensitivity—Ramipril—coronary artery disease	2.76e-05	0.000183	CcSEcCtD
Dorzolamide—Rash—Losartan—coronary artery disease	2.75e-05	0.000183	CcSEcCtD
Dorzolamide—Dermatitis—Losartan—coronary artery disease	2.75e-05	0.000183	CcSEcCtD
Dorzolamide—Headache—Losartan—coronary artery disease	2.73e-05	0.000182	CcSEcCtD
Dorzolamide—Urticaria—Lisinopril—coronary artery disease	2.7e-05	0.000179	CcSEcCtD
Dorzolamide—Hypersensitivity—Timolol—coronary artery disease	2.7e-05	0.000179	CcSEcCtD
Dorzolamide—Nausea—Furosemide—coronary artery disease	2.69e-05	0.000178	CcSEcCtD
Dorzolamide—Asthenia—Ramipril—coronary artery disease	2.69e-05	0.000178	CcSEcCtD
Dorzolamide—Abdominal pain—Lisinopril—coronary artery disease	2.68e-05	0.000178	CcSEcCtD
Dorzolamide—Body temperature increased—Lisinopril—coronary artery disease	2.68e-05	0.000178	CcSEcCtD
Dorzolamide—Pruritus—Ramipril—coronary artery disease	2.65e-05	0.000176	CcSEcCtD
Dorzolamide—Asthenia—Timolol—coronary artery disease	2.62e-05	0.000174	CcSEcCtD
Dorzolamide—Nausea—Losartan—coronary artery disease	2.59e-05	0.000172	CcSEcCtD
Dorzolamide—Pruritus—Timolol—coronary artery disease	2.59e-05	0.000172	CcSEcCtD
Dorzolamide—Diarrhoea—Ramipril—coronary artery disease	2.56e-05	0.00017	CcSEcCtD
Dorzolamide—Diarrhoea—Timolol—coronary artery disease	2.5e-05	0.000166	CcSEcCtD
Dorzolamide—Hypersensitivity—Lisinopril—coronary artery disease	2.5e-05	0.000166	CcSEcCtD
Dorzolamide—Dizziness—Ramipril—coronary artery disease	2.47e-05	0.000164	CcSEcCtD
Dorzolamide—Asthenia—Lisinopril—coronary artery disease	2.44e-05	0.000162	CcSEcCtD
Dorzolamide—Dizziness—Timolol—coronary artery disease	2.42e-05	0.000161	CcSEcCtD
Dorzolamide—Pruritus—Lisinopril—coronary artery disease	2.4e-05	0.000159	CcSEcCtD
Dorzolamide—Vomiting—Ramipril—coronary artery disease	2.38e-05	0.000158	CcSEcCtD
Dorzolamide—Rash—Ramipril—coronary artery disease	2.36e-05	0.000157	CcSEcCtD
Dorzolamide—Dermatitis—Ramipril—coronary artery disease	2.36e-05	0.000157	CcSEcCtD
Dorzolamide—Headache—Ramipril—coronary artery disease	2.34e-05	0.000156	CcSEcCtD
Dorzolamide—Vomiting—Timolol—coronary artery disease	2.33e-05	0.000154	CcSEcCtD
Dorzolamide—Diarrhoea—Lisinopril—coronary artery disease	2.32e-05	0.000154	CcSEcCtD
Dorzolamide—Rash—Timolol—coronary artery disease	2.31e-05	0.000153	CcSEcCtD
Dorzolamide—Dermatitis—Timolol—coronary artery disease	2.3e-05	0.000153	CcSEcCtD
Dorzolamide—Headache—Timolol—coronary artery disease	2.29e-05	0.000152	CcSEcCtD
Dorzolamide—Dizziness—Lisinopril—coronary artery disease	2.24e-05	0.000149	CcSEcCtD
Dorzolamide—Nausea—Ramipril—coronary artery disease	2.22e-05	0.000148	CcSEcCtD
Dorzolamide—Nausea—Timolol—coronary artery disease	2.17e-05	0.000144	CcSEcCtD
Dorzolamide—Vomiting—Lisinopril—coronary artery disease	2.16e-05	0.000143	CcSEcCtD
Dorzolamide—Rash—Lisinopril—coronary artery disease	2.14e-05	0.000142	CcSEcCtD
Dorzolamide—Dermatitis—Lisinopril—coronary artery disease	2.14e-05	0.000142	CcSEcCtD
Dorzolamide—Headache—Lisinopril—coronary artery disease	2.13e-05	0.000141	CcSEcCtD
Dorzolamide—Nausea—Lisinopril—coronary artery disease	2.02e-05	0.000134	CcSEcCtD
Dorzolamide—CA4—Metabolism—PPARG—coronary artery disease	6.19e-06	8.9e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—MTHFR—coronary artery disease	6.17e-06	8.87e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—SDC1—coronary artery disease	6.14e-06	8.83e-05	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PTGS2—coronary artery disease	6.1e-06	8.78e-05	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—POMC—coronary artery disease	6.1e-06	8.78e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—UGCG—coronary artery disease	6.02e-06	8.66e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PPAT—coronary artery disease	6.02e-06	8.66e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PLCD1—coronary artery disease	6.02e-06	8.66e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—MDH2—coronary artery disease	6.02e-06	8.66e-05	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PPARG—coronary artery disease	5.93e-06	8.53e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—AGT—coronary artery disease	5.86e-06	8.43e-05	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—POMC—coronary artery disease	5.85e-06	8.42e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PGM1—coronary artery disease	5.79e-06	8.34e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—APOE—coronary artery disease	5.74e-06	8.26e-05	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PPARG—coronary artery disease	5.69e-06	8.18e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—APOA1—coronary artery disease	5.67e-06	8.16e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—coronary artery disease	5.66e-06	8.15e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—coronary artery disease	5.61e-06	8.07e-05	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—POMC—coronary artery disease	5.61e-06	8.07e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PYGB—coronary artery disease	5.6e-06	8.05e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CKB—coronary artery disease	5.6e-06	8.05e-05	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—ALB—coronary artery disease	5.56e-06	8e-05	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—ALB—coronary artery disease	5.33e-06	7.67e-05	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—NOS3—coronary artery disease	5.32e-06	7.66e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PLIN1—coronary artery disease	5.26e-06	7.57e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—DLAT—coronary artery disease	5.26e-06	7.57e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PFKFB3—coronary artery disease	5.26e-06	7.57e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—COX5B—coronary artery disease	5.26e-06	7.57e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTM2—coronary artery disease	5.26e-06	7.57e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PPAP2B—coronary artery disease	5.24e-06	7.54e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CKM—coronary artery disease	5.24e-06	7.54e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—UQCRFS1—coronary artery disease	5.24e-06	7.54e-05	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—ALB—coronary artery disease	5.11e-06	7.36e-05	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—NOS3—coronary artery disease	5.1e-06	7.34e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—coronary artery disease	5e-06	7.2e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PPARG—coronary artery disease	5e-06	7.19e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SULT1E1—coronary artery disease	4.99e-06	7.18e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—POMC—coronary artery disease	4.93e-06	7.09e-05	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—NOS3—coronary artery disease	4.89e-06	7.04e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ALDH6A1—coronary artery disease	4.87e-06	7.01e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CKMT2—coronary artery disease	4.87e-06	7.01e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SULT4A1—coronary artery disease	4.87e-06	7.01e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PDK4—coronary artery disease	4.87e-06	7.01e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PYGM—coronary artery disease	4.87e-06	7.01e-05	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PTGS2—coronary artery disease	4.87e-06	7e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—POMC—coronary artery disease	4.85e-06	6.98e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—coronary artery disease	4.84e-06	6.97e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HK2—coronary artery disease	4.76e-06	6.84e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—AKR1B1—coronary artery disease	4.76e-06	6.84e-05	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PTGS2—coronary artery disease	4.67e-06	6.71e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SLC27A1—coronary artery disease	4.56e-06	6.56e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—ALB—coronary artery disease	4.5e-06	6.47e-05	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PTGS2—coronary artery disease	4.47e-06	6.44e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—LCAT—coronary artery disease	4.47e-06	6.44e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CPT1B—coronary artery disease	4.47e-06	6.44e-05	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—PIK3CA—coronary artery disease	4.46e-06	6.41e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—APOA4—coronary artery disease	4.39e-06	6.32e-05	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—PIK3CA—coronary artery disease	4.34e-06	6.25e-05	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PIK3CA—coronary artery disease	4.34e-06	6.25e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HMGCS2—coronary artery disease	4.34e-06	6.24e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PFKM—coronary artery disease	4.34e-06	6.24e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—LDHA—coronary artery disease	4.34e-06	6.24e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GYG1—coronary artery disease	4.34e-06	6.24e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GK—coronary artery disease	4.34e-06	6.24e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GATM—coronary artery disease	4.34e-06	6.24e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	4.31e-06	6.2e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—NOS3—coronary artery disease	4.3e-06	6.19e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GCLM—coronary artery disease	4.24e-06	6.1e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PDHA1—coronary artery disease	4.24e-06	6.1e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—AK1—coronary artery disease	4.14e-06	5.96e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GCH1—coronary artery disease	4.14e-06	5.96e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	4.11e-06	5.91e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—TXNRD1—coronary artery disease	4.11e-06	5.91e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP11B2—coronary artery disease	4.11e-06	5.91e-05	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PIK3CA—coronary artery disease	4.05e-06	5.83e-05	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PIK3CA—coronary artery disease	4.05e-06	5.83e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SLC22A3—coronary artery disease	4.05e-06	5.82e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ARNTL—coronary artery disease	3.99e-06	5.74e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HADH—coronary artery disease	3.99e-06	5.74e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PLCD1—coronary artery disease	3.97e-06	5.71e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PPAT—coronary artery disease	3.97e-06	5.71e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—MDH2—coronary artery disease	3.97e-06	5.71e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—UGCG—coronary artery disease	3.97e-06	5.71e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PTGS2—coronary artery disease	3.93e-06	5.66e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	3.92e-06	5.65e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	3.83e-06	5.51e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PGM1—coronary artery disease	3.82e-06	5.5e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—APOA2—coronary artery disease	3.78e-06	5.44e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GPX2—coronary artery disease	3.78e-06	5.44e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PLA2G2A—coronary artery disease	3.78e-06	5.44e-05	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PIK3CA—coronary artery disease	3.76e-06	5.4e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HK1—coronary artery disease	3.73e-06	5.37e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SULT1A1—coronary artery disease	3.73e-06	5.37e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ABCG5—coronary artery disease	3.73e-06	5.37e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GPX4—coronary artery disease	3.73e-06	5.37e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	3.73e-06	5.37e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CKB—coronary artery disease	3.69e-06	5.31e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PYGB—coronary artery disease	3.69e-06	5.31e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HADHA—coronary artery disease	3.69e-06	5.31e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTA1—coronary artery disease	3.65e-06	5.25e-05	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—AKT1—coronary artery disease	3.64e-06	5.24e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—LPA—coronary artery disease	3.61e-06	5.19e-05	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—AKT1—coronary artery disease	3.55e-06	5.1e-05	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—AKT1—coronary artery disease	3.55e-06	5.1e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PLCB3—coronary artery disease	3.49e-06	5.02e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PLIN1—coronary artery disease	3.47e-06	4.99e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—DLAT—coronary artery disease	3.47e-06	4.99e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTM2—coronary artery disease	3.47e-06	4.99e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PFKFB3—coronary artery disease	3.47e-06	4.99e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—COX5B—coronary artery disease	3.47e-06	4.99e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—APOA5—coronary artery disease	3.46e-06	4.97e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—P4HB—coronary artery disease	3.39e-06	4.88e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	3.36e-06	4.83e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PLA2G1B—coronary artery disease	3.33e-06	4.79e-05	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—AKT1—coronary artery disease	3.31e-06	4.76e-05	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—AKT1—coronary artery disease	3.31e-06	4.76e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	3.29e-06	4.73e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SULT1E1—coronary artery disease	3.29e-06	4.73e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	3.25e-06	4.68e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—AKR1B1—coronary artery disease	3.14e-06	4.51e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HK2—coronary artery disease	3.14e-06	4.51e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—VCAN—coronary artery disease	3.14e-06	4.51e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ALDOA—coronary artery disease	3.11e-06	4.48e-05	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—AKT1—coronary artery disease	3.07e-06	4.41e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—DCN—coronary artery disease	3.02e-06	4.35e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SLC27A1—coronary artery disease	3.01e-06	4.33e-05	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PIK3CA—coronary artery disease	2.99e-06	4.31e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CPT1B—coronary artery disease	2.95e-06	4.24e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—LCAT—coronary artery disease	2.95e-06	4.24e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ALDH2—coronary artery disease	2.94e-06	4.23e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—APOA4—coronary artery disease	2.9e-06	4.17e-05	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PIK3CA—coronary artery disease	2.87e-06	4.13e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	2.87e-06	4.12e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—LIPC—coronary artery disease	2.86e-06	4.12e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HBA1—coronary artery disease	2.86e-06	4.12e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP2C19—coronary artery disease	2.86e-06	4.12e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PIK3C2A—coronary artery disease	2.86e-06	4.12e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—APOC3—coronary artery disease	2.85e-06	4.1e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—LDLR—coronary artery disease	2.83e-06	4.07e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	2.83e-06	4.07e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PDHA1—coronary artery disease	2.8e-06	4.02e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GCLM—coronary artery disease	2.8e-06	4.02e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SLC9A1—coronary artery disease	2.8e-06	4.02e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTT1—coronary artery disease	2.8e-06	4.02e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GCLC—coronary artery disease	2.76e-06	3.98e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CETP—coronary artery disease	2.76e-06	3.98e-05	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PIK3CA—coronary artery disease	2.75e-06	3.96e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SDC1—coronary artery disease	2.73e-06	3.93e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—TXNRD1—coronary artery disease	2.71e-06	3.9e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP11B2—coronary artery disease	2.71e-06	3.9e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SLC22A3—coronary artery disease	2.67e-06	3.84e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HADH—coronary artery disease	2.63e-06	3.78e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ARNTL—coronary artery disease	2.63e-06	3.78e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PSMB5—coronary artery disease	2.58e-06	3.71e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PSMA6—coronary artery disease	2.58e-06	3.71e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	2.58e-06	3.71e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CTGF—coronary artery disease	2.52e-06	3.63e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HMGCR—coronary artery disease	2.5e-06	3.6e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GOT2—coronary artery disease	2.5e-06	3.6e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—APOA2—coronary artery disease	2.49e-06	3.59e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GPX2—coronary artery disease	2.49e-06	3.59e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	2.49e-06	3.59e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SULT1A1—coronary artery disease	2.46e-06	3.54e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HK1—coronary artery disease	2.46e-06	3.54e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ABCG5—coronary artery disease	2.46e-06	3.54e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GPX4—coronary artery disease	2.46e-06	3.54e-05	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—AKT1—coronary artery disease	2.45e-06	3.52e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HADHA—coronary artery disease	2.43e-06	3.5e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PIK3CA—coronary artery disease	2.42e-06	3.48e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTA1—coronary artery disease	2.4e-06	3.46e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—LPA—coronary artery disease	2.38e-06	3.42e-05	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—AKT1—coronary artery disease	2.35e-06	3.37e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PLCB3—coronary artery disease	2.3e-06	3.31e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PLCB1—coronary artery disease	2.3e-06	3.31e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—APOA5—coronary artery disease	2.28e-06	3.28e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	2.25e-06	3.24e-05	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—AKT1—coronary artery disease	2.25e-06	3.23e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—P4HB—coronary artery disease	2.24e-06	3.22e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ABCA1—coronary artery disease	2.23e-06	3.2e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	2.19e-06	3.16e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GOT1—coronary artery disease	2.16e-06	3.1e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GGT1—coronary artery disease	2.16e-06	3.1e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—VCAN—coronary artery disease	2.07e-06	2.98e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ALDOA—coronary artery disease	2.05e-06	2.95e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—DCN—coronary artery disease	1.99e-06	2.87e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—AKT1—coronary artery disease	1.98e-06	2.84e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ALDH2—coronary artery disease	1.94e-06	2.79e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTP1—coronary artery disease	1.94e-06	2.79e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	1.92e-06	2.76e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HMOX1—coronary artery disease	1.91e-06	2.75e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—LIPC—coronary artery disease	1.89e-06	2.72e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HBA1—coronary artery disease	1.89e-06	2.72e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP2C19—coronary artery disease	1.89e-06	2.72e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	1.89e-06	2.72e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CAT—coronary artery disease	1.89e-06	2.71e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—APOC3—coronary artery disease	1.88e-06	2.7e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—LDLR—coronary artery disease	1.87e-06	2.68e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SLC9A1—coronary artery disease	1.84e-06	2.65e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTT1—coronary artery disease	1.84e-06	2.65e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—APOB—coronary artery disease	1.83e-06	2.63e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GCLC—coronary artery disease	1.82e-06	2.62e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CETP—coronary artery disease	1.82e-06	2.62e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SDC1—coronary artery disease	1.8e-06	2.59e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTM1—coronary artery disease	1.78e-06	2.56e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—LPL—coronary artery disease	1.75e-06	2.51e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GPX1—coronary artery disease	1.71e-06	2.45e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PSMA6—coronary artery disease	1.7e-06	2.45e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PSMB5—coronary artery disease	1.7e-06	2.45e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CTGF—coronary artery disease	1.66e-06	2.39e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CD36—coronary artery disease	1.66e-06	2.39e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HMGCR—coronary artery disease	1.65e-06	2.37e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GOT2—coronary artery disease	1.65e-06	2.37e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PPP2CA—coronary artery disease	1.64e-06	2.36e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—MTHFR—coronary artery disease	1.57e-06	2.26e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PLCB1—coronary artery disease	1.52e-06	2.18e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—AGT—coronary artery disease	1.5e-06	2.15e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.47e-06	2.11e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—APOE—coronary artery disease	1.47e-06	2.11e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—APOA1—coronary artery disease	1.45e-06	2.08e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GGT1—coronary artery disease	1.42e-06	2.05e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GOT1—coronary artery disease	1.42e-06	2.05e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.39e-06	2e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.28e-06	1.84e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PPARG—coronary artery disease	1.28e-06	1.84e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.27e-06	1.82e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.26e-06	1.81e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—POMC—coronary artery disease	1.26e-06	1.81e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CAT—coronary artery disease	1.24e-06	1.79e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—APOB—coronary artery disease	1.21e-06	1.74e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.17e-06	1.69e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—LPL—coronary artery disease	1.15e-06	1.66e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ALB—coronary artery disease	1.15e-06	1.65e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GPX1—coronary artery disease	1.12e-06	1.62e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—NOS3—coronary artery disease	1.1e-06	1.58e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CD36—coronary artery disease	1.1e-06	1.58e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.08e-06	1.56e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.04e-06	1.49e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PTGS2—coronary artery disease	1e-06	1.44e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—AGT—coronary artery disease	9.86e-07	1.42e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—APOE—coronary artery disease	9.66e-07	1.39e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—APOA1—coronary artery disease	9.55e-07	1.37e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PPARG—coronary artery disease	8.42e-07	1.21e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—POMC—coronary artery disease	8.3e-07	1.19e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ALB—coronary artery disease	7.57e-07	1.09e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NOS3—coronary artery disease	7.24e-07	1.04e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PTGS2—coronary artery disease	6.62e-07	9.53e-06	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PIK3CA—coronary artery disease	6.18e-07	8.89e-06	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—AKT1—coronary artery disease	5.05e-07	7.26e-06	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PIK3CA—coronary artery disease	4.07e-07	5.86e-06	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—AKT1—coronary artery disease	3.33e-07	4.79e-06	CbGpPWpGaD
